Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional - and often ineffective - advice to "eat ...

"But at $700 a month, that's not going to happen." Even as weight loss drugs such as Wegovy and Zepbound explode in ...

State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...

Last year’s study in the journal Obesity had revealed that of people prescribed weight-loss drugs, just 44 per cent were ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...